Log InCreate an Account
  • Home
  • Contact us
  • SCAI.org Home |
  • SecondsCount.org |
  • eLearning Library |
  • Contribute to SCAI PAC |
  • my.scai.org
  • My SCAI
  • My Community
  • Member Directory
 Menu
  • Overview
  • Case Studies
  • Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 7.3: Heparin and Low Molecular Weight Heparins

    Neal Kleiman, MD — The Methodist Hospital, Baylor College of Medicine

    Duration:1 hour

    Faculty Disclosure

    • Grant and/or Research Support: Millennium Therapeutics; The Medicines Company
    • Consultant: Sanofi-Aventis

    Learning Objectives

    • Review the historical background of heparin, its activities, and dosage
    • Describe the clinical features of heparin-induced thrombocytopenia
    • Discuss low molecular weight heparins and pentasaccharide: comparative pharmacology and clinical trial results
* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:
* Message:
 

Thank you

Your feedback has been sent.